R

    Rxsight Inc (RXST)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $7.33
    +0.28 (+3.97%)

    Market Cap: $293.23M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    71%(15/21)
    Avg Surprise
    +16.90%
    Streak
    1 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.15
    Range$-0.31 - $0.09
    5 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$-0.17-9.3%
    60d ago$-0.17-9.3%
    30d ago$-0.17-9.3%
    7d ago$-0.16-5.1%
    Current$-0.15
    Revenue Consensus
    $27M
    Range$25M - $29M
    10 analysts
    Dec 31, 2026
    EPS Consensus$0.21
    Range$0.04 - $0.33
    5 analysts
    Revenue Consensus
    $58M
    Range$33M - $64M
    10 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.21---
    Sep 26EST
    		-$-0.15---
    Jun 26
    		$-0.29$-0.37+21.62%Beat+0.0%
    Mar 26
    		$-0.19$-0.15-26.67%Miss-533.3%
    Dec 25
    		$-0.03N/A+91.12%Beat-200.0%
    Sep 25
    		$-0.24$-0.34+29.41%Beat-50.0%
    Jun 25
    		$-0.29$-0.28-3.57%Miss-81.2%
    Mar 25
    		$-0.03N/A+62.50%Beat+75.0%
    Dec 24
    		$0.03N/A+117.65%Beat+111.5%
    Sep 24
    		$-0.16$-0.07-128.57%Miss+15.8%
    Jun 24
    		$-0.16$-0.11-45.45%Miss+42.9%
    Mar 24
    		$-0.12$-0.19+36.84%Beat+61.3%
    Dec 23
    		$-0.26$-0.36+27.78%Beat+53.6%
    Sep 23
    		$-0.19$-0.35+45.71%Beat+68.9%
    Jun 23
    		$-0.28$-0.39+28.21%Beat+54.1%
    Mar 23
    		$-0.31$-0.45+31.11%Beat+51.6%
    Dec 22
    		$-0.56$-0.75+25.33%Beat+3.4%
    Sep 22
    		$-0.61$-0.68+10.29%Beat+10.3%
    Jun 22
    		$-0.61$-0.65+6.15%Beat-19.6%
    Mar 22
    		$-0.64$-0.60-6.67%Miss-77.8%
    Dec 21
    		$-0.58$-0.68+14.71%Beat+65.9%
    Sep 21
    		$-0.68$-0.62-9.68%Miss-
    Jun 21
    		$-0.51$-0.70+27.14%Beat-
    Mar 21
    		$-0.36$0.00N/AMiss-
    Dec 20
    		$-1.70$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-9.77EV/EBITDA-7.70x
    Price/FCF-11.20xFCF Yield-8.93%
    Profitability
    Profit Margin-36.80%Operating Margin-40.80%
    ROE-17.30%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage-3936.64x
    Current Ratio4.07xQuick Ratio3.61x
    Trading Statistics
    Beta1.13Avg Volume897.71K
    52-Week High$13.2252-Week Low$4.48

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$6.49
    SMA 20$6.54
    SMA 50$5.87
    SMA 200$7.62
    EMA 10$6.67
    EMA 20$6.47
    EMA 50$6.14
    EMA 200$7.67

    MACD

    Line: 0.26Signal: 0.22Hist: 0.04

    ADX

    ADX: 15.1+DI: 32.7-DI: 16.5

    Aroon & PSAR

    Aroon Up100.0
    Aroon DownN/A
    PSAR$6.22

    Bollinger Bands

    Upper Band$7.31
    Lower Band$5.78
    %B Position2338%(Upper)
    Band Width1.02

    RSI (14-Day)

    Overbought
    70.1

    Momentum Oscillators

    Stoch %K78.9
    Stoch %D61.2
    Williams %R-2.1
    ROC (10d)13.1%
    Momentum0.85
    CCI (20d)156.5
    MFI (14d)63.1

    Volatility Measures

    ATR (14d)$0.39(5.4%)
    StdDev (20d)0.38
    Hist Vol54.3%(High)

    Volume Flow

    VWAP$7.23
    OBV-18.8M
    AD Line19.2M
    CMF (20d)0.291

    Volume Metrics

    Avg Vol (20d)880.9K
    Vol Ratio1.5x
    VWMA (20d)$6.56

    Pivot Points

    R3$7.73
    R2$7.40
    R1$7.22
    Pivot Point$6.89
    S1$6.71
    S2$6.38
    S3$6.20

    Advanced Oscillators

    TSI20.93
    Ultimate Osc65.5
    KST150.42

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$33.74M$30.89M$32.61M$30.34M$33.64M$37.90M$40.21M$35.31M$34.89M$29.51M$28.58M$22.20M
    Cost of Revenue$0$7.39M$7.34M$6.11M$0$9.57M$11.43M$10.09M$10.64M$8.83M$10.93M$8.47M
    Gross Profit$33.74M$23.50M$25.26M$24.23M$33.64M$28.33M$28.79M$25.22M$24.25M$20.68M$17.65M$13.73M
    Operating Expenses$47.51M$41.33M$36.60M$36.41M$47.64M$39.00M$37.42M$34.45M$32.58M$31.36M$28.50M$26.24M
    R&D$9.24M$9.47M$8.90M$9.06M$10.22M$10.37M$9.21M$8.84M$8.29M$8.03M$7.34M$7.10M
    SG&A$30.42M$31.86M$27.69M$27.34M$28.98M$28.64M$28.21M$25.61M$24.29M$23.32M$21.16M$19.14M
    Operating Income$-13,770,000$-17,829,000$-11,336,000$-12,178,000$-14,003,000$-10,674,000$-8,629,000$-9,226,000$-8,333,000$-10,670,000$-10,851,000$-12,512,000
    Interest Income$1.76M$1.95M$2.19M$2.38M$2.25M$2.51M$2.71M$2.91M$2.28M$1.58M$1.66M$1.75M
    Interest Expense$3,000$3,000$4,000$4,000$5,000$6,000$4,000$5,000$6,000$6,000$3,000$1.64M
    Income Before Tax$-12,009,000$-15,878,000$-9,146,000$-9,806,000$-11,754,000$-8,172,000$-5,926,000$-6,325,000$-6,063,000$-9,091,000$-9,195,000$-12,403,000
    Income Tax Expense$88,000$6,000$6,000$10,000$32,000$18,000$12,000$13,000$16,000$9,000$-18,000$12,000
    Net Income$-12,097,000$-15,884,000$-9,152,000$-9,816,000$-11,786,000$-8,190,000$-5,938,000$-6,338,000$-6,079,000$-9,100,000$-9,177,000$-12,415,000
    EBITDA$-14,523,000$-18,849,000$-12,317,000$-13,468,000$-15,357,000$-12,300,000$-10,783,000$-10,856,000$-9,586,000$-11,035,000$-11,509,000$-12,970,000
    EBIT$-13,770,000$-17,829,000$-11,336,000$-12,178,000$-14,003,000$-10,674,000$-8,629,000$-9,226,000$-8,333,000$-10,670,000$-10,851,000$-12,512,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about RXST

    News

    RxSight (NASDAQ: RXST) refreshes documents for option exchange

    RxSight, Inc. (NASDAQ: RXST) has amended its employee stock option exchange program, primarily to update the list of associated documents and materials. The Exchange Offer allows eligible employees to swap existing stock options for new equity awards under the terms of the Offer to Exchange dated August 10, 2026, and is tied to the company’s 2021 Equity Incentive Plan. This amendment does not alter the fundamental structure of the Exchange Offer itself.

    Stock Titan•8/25/26•
    Neutral

    Tocqueville Asset Management L.P. Makes New Investment in RxSight, Inc. $RXST

    Tocqueville Asset Management L.P. has made a new investment in RxSight, Inc. (NASDAQ:RXST), acquiring 265,000 shares valued at approximately $1.28 million, representing 0.64% of the company. Despite beating Q2 earnings estimates, RxSight remains unprofitable with a negative net margin. Institutional investors collectively own 78.78% of the company, and analysts have a consensus "Reduce" rating with an average price target of $8.37.

    MarketBeat•8/21/26•
    Neutral

    Steven Cohen’s Point72 discloses RxSight (RXST) stake

    Steven Cohen's Point72 Asset Management, along with Point72 Capital Advisors, Inc., has disclosed a beneficial ownership of 2,487,468 shares of RxSight, Inc. (RXST) common stock, representing 6.0% of the class. This stake was reported as of August 18, 2026, through a Schedule 13G filing, indicating shared voting and dispositive power. The shares are managed by Point72 Asset Management via Point72 Associates, LLC, an investment fund.

    Stock Titan•8/19/26•
    Neutral

    Vitruvian Partners LLP Purchases New Holdings in RxSight, Inc. $RXST

    Vitruvian Partners LLP has acquired a new stake of 278,865 shares in RxSight, Inc. (NASDAQ:RXST) during the second quarter, making it their 8th largest holding and representing approximately 0.7% of their investment portfolio. Despite this new investment and RxSight beating quarterly earnings expectations, the company currently holds an average analyst rating of "Reduce" with a target price of $8.37. Other institutional investors have also adjusted their positions in RxSight, with institutional ownership reaching 78.78%.

    MarketBeat•8/19/26•
    Neutral

    RxSight (NASDAQ: RXST) ex-director to sell 11,890 shares

    RxSight, Inc. (NASDAQ: RXST) has reported through a Form 144 SEC filing that former director Raymond W. Cohen intends to sell 11,890 shares of common stock. The proposed sale, valued at $75,748.81, will be executed via Morgan Stanley Smith Barney LLC on NASDAQ. This disclosure signals a potential insider sale under Rule 144, rather than a company-initiated transaction.

    Stock Titan•8/18/26•
    Neutral

    Frequently Asked Questions About RXST

    Does RXST pay dividends?
    Rxsight Inc (RXST) does not currently pay a regular dividend.
    What is RXST's market cap?
    Rxsight Inc (RXST) has a market capitalization of $293.23M with a current stock price of $7.33.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In